Although TGF-β is frequently present in the tumor microenvironment, initially as a signal to prevent premalignant progression, our data suggest that malignant cells can circumvent this suppressive effects by reactivation of the cell cycle arrest in CLL. Here, TGFB1 is linked to neoplasm.